Profile
Alan Tyndall is the founder of Magenta Therapeutics, Inc. (2015).
He is currently a Professor-Emeritus at the University of Basel (since 1991) and serves as Secretary at the World Scleroderma Foundation.
Mr. Tyndall received his undergraduate degree from the University of Sydney in 1972.
Mr. Tyndall is also the founder of Iterata AG.
Alan Tyndall active positions
| Companies | Position | Start |
|---|---|---|
University of Basel
University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1991 |
World Scleroderma Foundation | Corporate Secretary | - |
Iterata AG | Founder | - |
Former positions of Alan Tyndall
| Companies | Position | End |
|---|---|---|
| MAGENTA THERAPEUTICS | Founder | - |
Training of Alan Tyndall
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
The University of Sydney
The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Basel
University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Magenta Therapeutics, Inc.
Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
World Scleroderma Foundation | |
Iterata AG |
- Stock Market
- Insiders
- Alan Tyndall
















